A Not So Humerus Update on Osteoporosis Treatment Guidelines

March 31, 2022

The purpose of this activity is to review the pathophysiology, classify disease severity, and management of osteoporosis in adults – providing pharmacists and pharmacy technicians with updated practice guidelines and recommendations to help ensure safe, optimal, and ideal patient care practice. Specifically, treatment will focus on three classes of medications bisphosphonates, anti-receptor activator of nuclear factor kappa beta ligand (RANKL), and sclerostin inhibitors.

Target Audience

Pharmacists

Pharmacy tech

Learning Objectives

Pharmacist’s objectives:

  1. Describe the pathophysiology, diagnosis, and treatment for osteoporosis
  2. Review and discuss the updated recommendations in pharmacological treatment of osteoporosis including romoszumab
  3. Outline the pharmacological therapies for osteoporosis including drug holidays and adverse effects  

 

Pharmacy tech objective:

  1. Identify medications used in osteoporosis including romoszumab
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
03/11/2022
Course expires: 
05/15/2022
Event starts: 
03/31/2022 - 12:30pm CDT
Event ends: 
03/31/2022 - 1:30pm CDT
Cost:
$0.00
Live via webinar
United States

Relevant financial relationships: Planning committee members and presenters have nothing to disclose.

 

Planning committee members

 

Amanda Schartel, PharmD, BCACP

Clinical Pharmacist Specialist

ChristianaCare

 

Kelly Ko, PharmD

PGY-1 Pharmacy Resident

ChristianaCare

 

 

Presenter

 

Kelly Ko, PharmD

PGY-1 Pharmacy Resident

ChristianaCare

 

 

 

Joint Accreditation Statement:

 

In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Designation Statement:

PHARMACY

Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours. 
Universal Activity Number: JA0006103-9999-22-130-L01-P  and  JA0006103-9999-22-130-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician

Price

Cost:
$0.00
Please login or register to take this course.